MX9303165A - Preparaciones farmaceuticas estables de nicorandil - Google Patents

Preparaciones farmaceuticas estables de nicorandil

Info

Publication number
MX9303165A
MX9303165A MX9303165A MX9303165A MX9303165A MX 9303165 A MX9303165 A MX 9303165A MX 9303165 A MX9303165 A MX 9303165A MX 9303165 A MX9303165 A MX 9303165A MX 9303165 A MX9303165 A MX 9303165A
Authority
MX
Mexico
Prior art keywords
nicorandil
pharmaceutical preparations
stable
stable pharmaceutical
dimethyl polysiloxanes
Prior art date
Application number
MX9303165A
Other languages
English (en)
Inventor
Veronesi Paolo Alberto
Veronesi Anna Maria
Original Assignee
Therapicon Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Therapicon Srl filed Critical Therapicon Srl
Publication of MX9303165A publication Critical patent/MX9303165A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Composiciones estables de nicorandil han sido obtenidas preparando suspensiones de principio activo en dimetil polisiloxanos (dimeticona) a baja densidad para uso farmacéutico, con las cuales han sido llenadas cápsulas blandas o duras de gelatina. Los dimetil polisiloxanos a baja densidad han mostrado de ser químicamente compatibles con nicorandil y de preservar eficazmente de la humedad las preparaciones farmacéuticas así obtenidas, rendiendolas más estables para los normales tiempos de conservación.
MX9303165A 1992-06-08 1993-05-28 Preparaciones farmaceuticas estables de nicorandil MX9303165A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI921413A IT1256022B (it) 1992-06-08 1992-06-08 Preparazioni farmaceutiche stabili di nicorandil

Publications (1)

Publication Number Publication Date
MX9303165A true MX9303165A (es) 1993-12-31

Family

ID=11363474

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9303165A MX9303165A (es) 1992-06-08 1993-05-28 Preparaciones farmaceuticas estables de nicorandil

Country Status (10)

Country Link
US (1) US5580576A (es)
EP (1) EP0574221B1 (es)
JP (1) JP2893307B2 (es)
KR (1) KR100196212B1 (es)
AT (1) ATE197671T1 (es)
DE (1) DE69329691T2 (es)
ES (1) ES2153835T3 (es)
IT (1) IT1256022B (es)
MX (1) MX9303165A (es)
PT (1) PT574221E (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6129673A (en) * 1998-06-08 2000-10-10 Advanced Monitors, Corp. Infrared thermometer
JP4472035B2 (ja) * 1998-06-17 2010-06-02 森下仁丹株式会社 長期保存安定性に優れたカプセル製剤
US20040151785A1 (en) * 1998-10-06 2004-08-05 Diamedica Inc. Method for treating insulin resistance through hepatic nitric oxide
AU3810100A (en) * 1999-03-12 2000-10-04 Basf Aktiengesellschaft Stable pharmaceutical application form for paroxetin anhydrate
WO2000067754A1 (en) 1999-05-12 2000-11-16 Nitromed, Inc. Nitrosated and nitrosylated potassium channel activators, compositions and methods of use
US20090035260A1 (en) * 2002-07-29 2009-02-05 Therapicon Srl Enhanced nasal composition of active peptide
FR2850275B1 (fr) * 2003-01-24 2005-04-08 Scherer Technologies Inc R P Capsules molles a macher contenant une substance active a gout masque
DE10328260A1 (de) * 2003-06-23 2005-01-27 Schmidt, K.-G., Dr. med. Flupirtine-Präparat
JP4740740B2 (ja) 2003-12-09 2011-08-03 大日本住友製薬株式会社 薬物含有粒子および該粒子を含む固形製剤
ITMI20040235A1 (it) * 2004-02-13 2004-05-13 Therapicon Srl Preparazione farmaceutica per il cavo orale
US20070281008A1 (en) * 2006-06-05 2007-12-06 Lin Shun Y Personal lubricant compositions and kits for providing personal lubrication
US20140044779A1 (en) * 2011-04-18 2014-02-13 Lipidor Ab Liquid Carrier for Oral Delivery of a Pharmacologically Active Agent
WO2013173923A1 (en) 2012-05-25 2013-11-28 Diamedica, Inc. Formulations of human tissue kallikrein-1 for parenteral delivery and related methods
ES2625548T3 (es) 2012-06-04 2017-07-19 DiaMedica Therapeutics Inc. Isoformas de glicosilación de la calicreína-1 tisular humana
KR20190122706A (ko) 2017-03-09 2019-10-30 다이어메디카 인코포레이티드 조직 칼리크레인 1의 투약 형태
CN110123749B (zh) * 2019-06-03 2022-01-25 太阳升(亳州)生物医药科技有限公司 尼可地尔脂微球制剂及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0223811A1 (en) * 1985-05-22 1987-06-03 Beecham Group Plc Use of nicorandil or pinacidil for the treatment of peripheral vascular disease
US5188840A (en) * 1985-09-26 1993-02-23 Chugai Seiyaku Kabushiki Kaisha Slow-release pharmaceutical agent
JPS6351326A (ja) * 1986-08-22 1988-03-04 Nisshin Flour Milling Co Ltd ニコランジル外用剤
US5057317A (en) * 1987-03-24 1991-10-15 Chugai Seiyaku Kabushiki Kaisha Slow-release pharmaceutical agent
US4837029A (en) * 1987-04-06 1989-06-06 Carolina Medical Products, Inc. Low foaming, aqueously homogenizable rifampin composition
FR2624012B1 (fr) * 1987-12-07 1991-05-31 Fdb Ste Civile Rech Nouvelles compositions pharmaceutiques a action hypnotique a base d'hydrate de chloral
US5112604A (en) * 1989-09-01 1992-05-12 Riker Laboratories, Inc. Oral suspension formulation

Also Published As

Publication number Publication date
JP2893307B2 (ja) 1999-05-17
PT574221E (pt) 2001-04-30
ITMI921413A1 (it) 1993-12-08
ITMI921413A0 (it) 1992-06-08
KR100196212B1 (ko) 1999-06-15
IT1256022B (it) 1995-11-20
US5580576A (en) 1996-12-03
DE69329691T2 (de) 2001-05-10
ES2153835T3 (es) 2001-03-16
DE69329691D1 (de) 2000-12-28
EP0574221B1 (en) 2000-11-22
JPH0640916A (ja) 1994-02-15
EP0574221A1 (en) 1993-12-15
KR940000104A (ko) 1994-01-03
ATE197671T1 (de) 2000-12-15

Similar Documents

Publication Publication Date Title
MX9303165A (es) Preparaciones farmaceuticas estables de nicorandil
KE3164A (en) Optically active substituted-cyano-phenoxybenzyl isovalerates,their preparation and insecticidal compositions containing them
ES2187749T3 (es) Composicion agroquimica envasada.
IT1230742B (it) Composizione per aerosol comprendente nitroglicerina come ingrediente attivo.
MX9203480A (es) Formulaciones medicinales en aereosol.
IT1203515B (it) Complessi di saponine con fosfolipidi e composizioni farmaceutiche e cosmetiche che li contengono
ES2145836T3 (es) Copolimeros elastomericos termoplasticos injertados de silicona, y composiciones que los contienen para el cuidado del pelo y la piel.
GR3022641T3 (en) Stabilization of fluorocarbon emulsions.
PT91246A (pt) Processo para a preparacao de composicoes farmaceuticas para administracao endovenosa, contendo ciclosporina como ingrediente activo
IL53594A (en) Biological cells comprising pharmaceutically active substances and additives controlling their release from the cells,their preparation and pharmaceutical compositions containing them
MX9203504A (es) Complejo agente: lipido activo de alta proporcion.
PT100928A (pt) Derivados de ciclopentano e ciclopenteno, composicoes farmaceuticas contendo estes compostos e seu uso
IT1263840B (it) Formulazioni orali di ubidecarenone in forma di capsule
MX9205384A (es) Dispositivo de administracion transdermica de un agente activo para uso veterinario.
MXPA97007996A (es) Preparado para el transporte de sustancias activas a traves de barreras.
ATE301986T1 (de) Kosmetische stiftzubereitung
ATE72924T1 (de) Fungizide wirkstoffgemische.
DE69102704D1 (de) Orales, melatonin enthaltendes arzneimittel.
GB8900760D0 (en) Synergistic fungicidal and acaricidal and compositions containing two or three active ingredients
BR8802557A (pt) Agente fisiologicamente ativo para uso agricola
ES2124222T3 (es) Agentes edulcorantes de clorodesoxiazucar estabilizados en forma solida y procedimientos para su preparacion.
NO882509D0 (no) Nye pyrazolforbindelser og herbicide preparater inneholdende dem som aktive bestanddeler.
DK0693926T3 (da) Ny farmaceutisk sammensætning til fremstilling af et stabilt pulver indeholdende en kombination af acetylsalicylsyre og metoclopramid som aktiv bestanddel.
MX164799B (es) Composiciones que contienen azufre activo
GB2021409A (en) Pharmaceutical composition

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees